U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Adrenocorticotropin receptor defect

MedGen UID:
867190
Concept ID:
C4021548
Finding
Synonyms: ACTH receptor defect; ACTHR defect; Adrenocorticotropic hormone-resistant adrenal insufficiency
 
HPO: HP:0008259

Definition

Adrenal insufficiency secondary to a defect in the ACTH receptor. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAdrenocorticotropin receptor defect

Conditions with this feature

Glucocorticoid deficiency with achalasia
MedGen UID:
82889
Concept ID:
C0271742
Disease or Syndrome
Triple A syndrome is an inherited condition characterized by three specific features: achalasia, Addison disease, and alacrima. Achalasia is a disorder that affects the ability to move food through the esophagus, the tube that carries food from the throat to the stomach. It can lead to severe feeding difficulties and low blood glucose (hypoglycemia). Addison disease, also known as primary adrenal insufficiency, is caused by abnormal function of the small hormone-producing glands on top of each kidney (adrenal glands). The main features of Addison disease include fatigue, loss of appetite, weight loss, low blood pressure, and darkening of the skin. The third major feature of triple A syndrome is a reduced or absent ability to secrete tears (alacrima). Most people with triple A syndrome have all three of these features, although some have only two.\n\nMany of the features of triple A syndrome are caused by dysfunction of the autonomic nervous system. This part of the nervous system controls involuntary body processes such as digestion, blood pressure, and body temperature. People with triple A syndrome often experience abnormal sweating, difficulty regulating blood pressure, unequal pupil size (anisocoria), and other signs and symptoms of autonomic nervous system dysfunction (dysautonomia).\n\nPeople with this condition may have other neurological abnormalities, such as developmental delay, intellectual disability, speech problems (dysarthria), and a small head size (microcephaly). In addition, affected individuals commonly experience muscle weakness, movement problems, and nerve abnormalities in their extremities (peripheral neuropathy). Some develop optic atrophy, which is the degeneration (atrophy) of the nerves that carry information from the eyes to the brain. Many of the neurological symptoms of triple A syndrome worsen over time.\n\nPeople with triple A syndrome frequently develop a thickening of the outer layer of skin (hyperkeratosis) on the palms of their hands and the soles of their feet. Other skin abnormalities may also be present in people with this condition.\n\nAlacrima is usually the first noticeable sign of triple A syndrome, as it becomes apparent early in life that affected children produce little or no tears while crying. They develop Addison disease and achalasia during childhood or adolescence, and most of the neurologic features of triple A syndrome begin during adulthood. The signs and symptoms of this condition vary among affected individuals, even among members of the same family.

Professional guidelines

PubMed

Vassiliadi DA, Tsagarakis S
Endocr Relat Cancer 2019 Oct 1;26(10):R567-R581. doi: 10.1530/ERC-19-0240. PMID: 32053747
Ising M, Holsboer F
Exp Clin Psychopharmacol 2007 Dec;15(6):519-28. doi: 10.1037/1064-1297.15.6.519. PMID: 18179304
Chanson P, Salenave S
Minerva Endocrinol 2004 Dec;29(4):241-75. PMID: 15765032

Recent clinical studies

Etiology

Rasmusson AM, Pineles SL
Curr Psychiatry Rep 2018 Jul 17;20(7):52. doi: 10.1007/s11920-018-0908-9. PMID: 30019147
Belvederi Murri M, Prestia D, Mondelli V, Pariante C, Patti S, Olivieri B, Arzani C, Masotti M, Respino M, Antonioli M, Vassallo L, Serafini G, Perna G, Pompili M, Amore M
Psychoneuroendocrinology 2016 Jan;63:327-42. Epub 2015 Oct 21 doi: 10.1016/j.psyneuen.2015.10.014. PMID: 26547798
García M, Fernández A, Moreno JC
Endocr Dev 2014;26:79-107. Epub 2014 Aug 29 doi: 10.1159/000363157. PMID: 25231446
Cooray SN, Chan L, Metherell L, Storr H, Clark AJL
Endocr Dev 2008;13:99-116. doi: 10.1159/000134828. PMID: 18493136
Ferraz-de-Souza B, Achermann JC
Endocr Dev 2008;13:19-32. doi: 10.1159/000134753. PMID: 18493131

Diagnosis

Vitellius G, Lombes M
Eur J Endocrinol 2020 Feb 1;182(2):R15-R27. doi: 10.1530/EJE-19-0811. PMID: 31995340
Vassiliadi DA, Tsagarakis S
Endocr Relat Cancer 2019 Oct 1;26(10):R567-R581. doi: 10.1530/ERC-19-0240. PMID: 32053747
Maharaj A, Maudhoo A, Chan LF, Novoselova T, Prasad R, Metherell LA, Guasti L
J Steroid Biochem Mol Biol 2019 May;189:73-80. Epub 2019 Feb 25 doi: 10.1016/j.jsbmb.2019.02.012. PMID: 30817990
Slominski A, Wortsman J, Carlson AJ, Matsuoka LY, Balch CM, Mihm MC
Arch Pathol Lab Med 2001 Oct;125(10):1295-306. doi: 10.5858/2001-125-1295-MM. PMID: 11570904
Wajchenberg BL, Mendonça B, Liberman B, Adelaide M, Pereira A, Kirschner MA
J Steroid Biochem Mol Biol 1995 Jun;53(1-6):139-51. doi: 10.1016/0960-0760(95)00044-z. PMID: 7626446

Therapy

Vassiliadi DA, Tsagarakis S
Endocr Relat Cancer 2019 Oct 1;26(10):R567-R581. doi: 10.1530/ERC-19-0240. PMID: 32053747
Snow SJ, Henriquez AR, Costa DL, Kodavanti UP
Toxicol Sci 2018 Jul 1;164(1):9-20. doi: 10.1093/toxsci/kfy129. PMID: 29846720Free PMC Article
Videira IF, Moura DF, Magina S
An Bras Dermatol 2013 Jan-Feb;88(1):76-83. doi: 10.1590/s0365-05962013000100009. PMID: 23539007Free PMC Article
Hainerová IA, Lebl J
World Rev Nutr Diet 2013;106:105-12. Epub 2013 Feb 11 doi: 10.1159/000342556. PMID: 23428688
Sonino N, Boscaro M, Fallo F
Treat Endocrinol 2005;4(2):87-94. doi: 10.2165/00024677-200504020-00003. PMID: 15783246

Prognosis

Yamamoto M, Nakao T, Ogawa W, Fukuoka H
Front Endocrinol (Lausanne) 2021;12:650791. Epub 2021 Jun 16 doi: 10.3389/fendo.2021.650791. PMID: 34220707Free PMC Article
Snow SJ, Henriquez AR, Costa DL, Kodavanti UP
Toxicol Sci 2018 Jul 1;164(1):9-20. doi: 10.1093/toxsci/kfy129. PMID: 29846720Free PMC Article
Lim CT, Korbonits M
Endocr Pract 2018 May;24(5):473-488. Epub 2018 Mar 2 doi: 10.4158/EP-2018-0034. PMID: 29498920
Scott RR, Miller WL
Horm Res 2008;69(5):266-75. Epub 2008 Feb 6 doi: 10.1159/000114857. PMID: 18259105
Slominski A, Wortsman J, Carlson AJ, Matsuoka LY, Balch CM, Mihm MC
Arch Pathol Lab Med 2001 Oct;125(10):1295-306. doi: 10.5858/2001-125-1295-MM. PMID: 11570904

Clinical prediction guides

Snow SJ, Henriquez AR, Costa DL, Kodavanti UP
Toxicol Sci 2018 Jul 1;164(1):9-20. doi: 10.1093/toxsci/kfy129. PMID: 29846720Free PMC Article
Lim CT, Korbonits M
Endocr Pract 2018 May;24(5):473-488. Epub 2018 Mar 2 doi: 10.4158/EP-2018-0034. PMID: 29498920
Dunlop BW, Binder EB, Iosifescu D, Mathew SJ, Neylan TC, Pape JC, Carrillo-Roa T, Green C, Kinkead B, Grigoriadis D, Rothbaum BO, Nemeroff CB, Mayberg HS
Biol Psychiatry 2017 Dec 15;82(12):866-874. Epub 2017 Jul 4 doi: 10.1016/j.biopsych.2017.06.024. PMID: 28793974Free PMC Article
Ising M, Holsboer F
Exp Clin Psychopharmacol 2007 Dec;15(6):519-28. doi: 10.1037/1064-1297.15.6.519. PMID: 18179304
Slominski A, Wortsman J, Carlson AJ, Matsuoka LY, Balch CM, Mihm MC
Arch Pathol Lab Med 2001 Oct;125(10):1295-306. doi: 10.5858/2001-125-1295-MM. PMID: 11570904

Recent systematic reviews

Gregoric N, Groselj U, Bratina N, Debeljak M, Zerjav Tansek M, Suput Omladic J, Kovac J, Battelino T, Kotnik P, Avbelj Stefanija M
Front Endocrinol (Lausanne) 2021;12:689387. Epub 2021 Jun 9 doi: 10.3389/fendo.2021.689387. PMID: 34177811Free PMC Article
Belvederi Murri M, Prestia D, Mondelli V, Pariante C, Patti S, Olivieri B, Arzani C, Masotti M, Respino M, Antonioli M, Vassallo L, Serafini G, Perna G, Pompili M, Amore M
Psychoneuroendocrinology 2016 Jan;63:327-42. Epub 2015 Oct 21 doi: 10.1016/j.psyneuen.2015.10.014. PMID: 26547798

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...